Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof

Details for Australian Patent Application No. 2004255515 (hide)

Owner Archimedes Development Limited

Inventors Smith, Alan; Dyer, Ann Margaret; Watts, Peter James; Cheng, Yu-Hui

Agent Griffith Hack

Pub. Number AU-B-2004255515

PCT Pub. Number WO2005/004838

Priority 0315632.0 04.07.03 GB

Filing date 2 July 2004

Wipo publication date 20 January 2005

Acceptance publication date 30 April 2009

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 38/27 (2006.01) Medicinal preparations containing peptides - Growth hormone (GH) (Somatotropin)

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 47/36 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

Event Publications

2 February 2006 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 30 Dec 2005

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/004838 Priority application(s): WO2005/004838

30 April 2009 Application Accepted

  Published as AU-B-2004255515

27 August 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004255517-Novel process

2004255504-Novel solid pharmaceutical composition comprising amisulpride